Stock listing
BOATS:PCSA Processa Pharmaceuticals, Inc. Stock
US listing (BOATS) of Processa Pharmaceuticals, Inc. · home listing NASDAQ:PCSA
Follow Processa Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:PCSA
$1.89 USD 0.00 (0.0%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:PCSA
- Day range
- $1.81 – $1.94 USDOct 30, 2026
- Volume
- 25,323 sharesOct 30, 2026
- Market cap
- $5.29M USDAt the close on Oct 30, 2026 · price × 2.80M shares outstanding
- 52-week range
- $1.04 – $10.25 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $179,348 USDMedian day 25,412 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:PCSA · Home | $1.89 USD | 0.00 (0.0%) | 25,323 | $1.81 | $1.939 | $1.81 | $1.89 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:PCSA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.89 | 0.00 | 0.0% | $1.81 | $1.939 | $1.81 | 25,323 | |
| $1.89 | +0.04 | +2.2% | $1.84 | $2.10 | $1.80 | 104,807 | |
| $1.85 | +0.03 | +1.6% | $1.80 | $1.911 | $1.755 | 24,072 | |
| $1.82 | +0.025 | +1.4% | $1.76 | $1.87 | $1.706 | 13,367 | |
| $1.795 | -0.015 | -0.8% | $1.78 | $1.85 | $1.721 | 19,526 | |
| $1.81 | -0.05 | -2.7% | $1.761 | $1.90 | $1.751 | 35,000 | |
| $1.86 | +0.10 | +5.7% | $1.71 | $1.889 | $1.71 | 16,100 | |
| $1.76 | -0.03 | -1.7% | $1.79 | $1.79 | $1.68 | 11,700 | |
| $1.79 | +0.06 | +3.5% | $1.73 | $1.79 | $1.59 | 18,200 | |
| $1.73 | +0.04 | +2.4% | $1.74 | $1.74 | $1.69 | 19,700 | |
| $1.69 | +0.01 | +0.6% | $1.69 | $1.75 | $1.61 | 22,100 | |
| $1.68 | +0.065 | +4.0% | $1.58 | $1.72 | $1.53 | 31,100 | |
| $1.615 | -0.155 | -8.8% | $1.75 | $1.75 | $1.56 | 46,300 | |
| $1.77 | -0.13 | -6.8% | $1.93 | $1.93 | $1.77 | 69,200 | |
| $1.90 | +0.38 | +25.0% | $1.56 | $1.98 | $1.50 | 438,300 | |
| $1.52 | +0.17 | +12.6% | $1.32 | $1.87 | $1.041 | 2,969,000 | |
| $1.35 | -0.07 | -4.9% | $1.42 | $1.43 | $1.32 | 12,800 | |
| $1.42 | -0.10 | -6.6% | $1.53 | $1.53 | $1.41 | 12,900 | |
| $1.52 | +0.03 | +2.0% | $1.51 | $1.59 | $1.45 | 17,900 | |
| $1.49 | -0.12 | -7.5% | $1.56 | $1.63 | $1.49 | 25,700 | |
| $1.61 | -0.01 | -0.6% | $1.73 | $1.74 | $1.60 | 14,900 | |
| $1.62 | -0.02 | -1.2% | $1.59 | $1.645 | $1.57 | 10,200 | |
| $1.64 | -0.12 | -6.8% | $1.83 | $1.848 | $1.57 | 84,100 | |
| $1.76 | -0.08 | -4.3% | $1.76 | $1.83 | $1.75 | 9,300 | |
| $1.84 | 0.00 | 0.0% | $1.84 | $1.84 | $1.77 | 9,400 | |
| $1.84 | -0.01 | -0.5% | $1.88 | $1.93 | $1.80 | 8,500 | |
| $1.85 | -0.04 | -2.1% | $1.89 | $1.939 | $1.80 | 5,100 | |
| $1.89 | +0.01 | +0.5% | $1.90 | $1.97 | $1.865 | 4,700 | |
| $1.88 | +0.04 | +2.2% | $1.91 | $2.02 | $1.85 | 74,500 | |
| $1.84 | -0.12 | -6.1% | $1.87 | $1.944 | $1.84 | 16,500 | |
| $1.96 | +0.06 | +3.2% | $1.92 | $1.96 | $1.84 | 6,400 | |
| $1.90 | +0.05 | +2.7% | $1.85 | $1.99 | $1.85 | 21,800 | |
| $1.85 | -0.107 | -5.5% | $1.93 | $1.95 | $1.85 | 17,100 | |
| $1.957 | +0.077 | +4.1% | $1.95 | $1.96 | $1.88 | 15,600 | |
| $1.88 | -0.20 | -9.6% | $1.97 | $2.11 | $1.87 | 26,800 | |
| $2.08 | +0.23 | +12.4% | $1.90 | $2.12 | $1.90 | 39,300 | |
| $1.85 | -0.14 | -7.0% | $1.99 | $2.03 | $1.82 | 101,400 | |
| $1.99 | -0.17 | -7.9% | $2.08 | $2.11 | $1.98 | 25,500 | |
| $2.16 | +0.10 | +4.9% | $2.15 | $2.165 | $2.05 | 35,800 | |
| $2.06 | +0.01 | +0.5% | $2.02 | $2.083 | $2.01 | 12,300 | |
| $2.05 | -0.05 | -2.4% | $2.09 | $2.10 | $2.05 | 10,300 | |
| $2.10 | +0.05 | +2.4% | $2.05 | $2.18 | $2.05 | 12,400 | |
| $2.05 | 0.00 | 0.0% | $2.04 | $2.125 | $2.02 | 14,400 | |
| $2.05 | -0.01 | -0.5% | $2.08 | $2.11 | $2.02 | 15,700 | |
| $2.06 | -0.05 | -2.4% | $2.08 | $2.14 | $2.02 | 9,600 | |
| $2.11 | -0.02 | -0.9% | $2.07 | $2.20 | $2.07 | 15,900 | |
| $2.13 | -0.05 | -2.3% | $2.18 | $2.22 | $2.12 | 21,600 | |
| $2.18 | +0.01 | +0.5% | $2.17 | $2.28 | $2.15 | 54,500 | |
| $2.17 | +0.09 | +4.3% | $2.11 | $2.18 | $2.04 | 30,200 | |
| $2.08 | -0.065 | -3.0% | $2.21 | $2.22 | $2.00 | 75,900 | |
| $2.145 | -0.005 | -0.2% | $2.14 | $2.20 | $2.11 | 27,500 | |
| $2.15 | +0.05 | +2.4% | $2.18 | $2.18 | $2.11 | 25,100 | |
| $2.10 | -0.03 | -1.4% | $2.13 | $2.154 | $2.04 | 51,900 | |
| $2.13 | -0.30 | -12.3% | $2.43 | $2.43 | $2.12 | 61,200 | |
| $2.43 | -0.07 | -2.8% | $2.49 | $2.525 | $2.37 | 50,200 | |
| $2.50 | -0.06 | -2.3% | $2.57 | $2.59 | $2.46 | 38,400 | |
| $2.56 | -0.07 | -2.7% | $2.625 | $2.68 | $2.46 | 82,700 | |
| $2.63 | +0.02 | +0.8% | $2.62 | $2.68 | $2.57 | 45,600 | |
| $2.61 | +0.04 | +1.6% | $2.61 | $2.79 | $2.56 | 77,600 | |
| $2.57 | +0.27 | +11.7% | $2.36 | $2.64 | $2.32 | 113,000 | |
| $2.30 | +0.11 | +5.0% | $2.18 | $2.38 | $2.18 | 73,100 | |
| $2.19 | +0.07 | +3.3% | $2.10 | $2.25 | $2.10 | 65,600 | |
| $2.12 | -0.01 | -0.5% | $2.08 | $2.31 | $2.07 | 151,900 | |
| $2.13 | -0.02 | -0.9% | $2.05 | $2.22 | $2.05 | 98,000 | |
| $2.15 | +0.11 | +5.4% | $2.00 | $2.20 | $1.92 | 395,900 | |
| $2.04 | +0.01 | +0.5% | $1.91 | $2.18 | $1.90 | 455,000 |
- Ticker
- BOATS:PCSA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 29, 2026
Processa Pharmaceuticals Announces Corporate and Pipeline Progress Following Acquisition of Vidya Therapeutics
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 15 slides
Calls
Replays
Processa Pharmaceuticals (NASDAQ:PCSA) Q4 2022 Earnings Call
Thu, Mar 30, 2023 · 4:30 PM ET
Watch TranscriptProcessa Pharmaceuticals (NASDAQ:PCSA) Q3 2022 Earnings Call
Tue, Nov 08, 2022 · 4:30 PM ET
Watch TranscriptProcessa Pharmaceuticals (NASDAQ:PCSA) Q2 2022 Earnings Call
Thu, Aug 11, 2022 · 4:30 PM ET
Watch Transcript
Latest news
Processa Pharmaceuticals Announces Corporate and Pipeline Progress Following Acquisition of Vidya Therapeutics
Oct 29, 2026
Closed $1.89 (+2.2%) on Oct 29, 2026
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
Sep 1, 2026
Closed $2.05 (0.0%) on Sep 1, 2026
Processa Pharmaceuticals, Inc. announces acquisition of Vidya Therapeutics, Inc. and approximately $200 million concurrent private placement to advance BTK inhibitor, VT-7208, in multiple disease areas
Jul 29, 2026
Closed $2.03 (-33.4%) on Jul 29, 2026
Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference
Jan 12, 2026
Closed $3.14 (-6.5%) on Jan 12, 2026
Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study
Jan 5, 2026
Closed $3.23 (+10.2%) on Jan 5, 2026
Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer
Dec 17, 2025
Closed $6.68 (+122.7%) on Dec 17, 2025
Processa Pharmaceuticals Announces Poster Presentation of Adaptive Phase 2/3 PCS499 Study in FSGS at ASN Kidney Week 2025
Nov 5, 2025
Closed $8.50 (-1.7%) on Nov 5, 2025
Financings
Private placement of series A non-voting convertible preferred stock
Jul 29, 2026
Announced: about US$200M · US$1,221 a share · Leerink Partners +3
Dealers: Leerink Partners (lead), Evercore ISI, UBS Investment Bank, Wells Fargo Securities
Buyers: Bain Capital Life Sciences; Janus Henderson Investors; RA Capital Management; SilverArc Capital; ADAR1 Capital Management; Cormorant Asset Management; Integral Health Asset Management; Marshall Wace; Octagon Capital; Soleus Capital
Use of proceeds: Advance VT-7208 through Phase 2 proof-of-concept studies in food allergy, CSU and RMS; fund operations into second half of 2029
Decks
Investor Presentation (September 2026)
Investor deck · 15 slides · September 2026
Merger or Acquisition (July 2026)
Merger or acquisition · 15 slides · Jul 28, 2026
Investor Presentation (February 2025)
Investor deck · 25 slides · Feb 11, 2025
Investor Presentation (April 2024)
Investor deck · 16 slides · Apr 4, 2024
Processa Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 7 in the last 12 months · 87 in all · newest Oct 29, 2026 · oldest 2019
- Calls
- 6 calls with a replay · 6 with a transcript · latest Mar 30, 2023
- Decks
- 39 decks · latest September 2026
Where Processa Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:PCSA · Home listing | NASDAQ | United States | USD |
| BOATS:PCSA · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Processa Pharmaceuticals, Inc.